Itron, Inc. — Q1 2023 Form 10-Q Summary
Reporting period: Three months ended March 31, 2023; comparisons are with the three months ended March 31, 2022 unless noted. Itron provides smart networks, devices, software, and services for utilities and municipalities.
Financial performance
| Metric | Q1 2023 | Q1 2022 | Change |
|---|---|---|---|
| Revenue | $494.6 million | $475.3 million | +4% |
| Gross profit / margin | $156.4 million / 31.6% | $135.2 million / 28.4% | Margin +3.2 percentage points |
| Operating expenses | $166.8 million | $128.4 million | +$38.4 million |
| GAAP operating income (loss) | $(10.4) million | $6.8 million | Decreased |
| Net income (loss) attributable to Itron | $(11.8) million | $0.9 million | Decreased |
| GAAP diluted EPS | $(0.26) | $0.02 | Decreased |
| Non-GAAP net income / diluted EPS | $22.4 million / $0.49 | $5.2 million / $0.11 | Both increased |
| Adjusted EBITDA | $39.5 million | $18.9 million | +109% |
| Operating cash flow / free cash flow | $1.4 million / $(5.5) million | $7.6 million / $2.2 million | Both decreased |
Revenue growth reflected Networked Solutions and Outcomes, partly offset by lower Device Solutions revenue. Foreign exchange reduced reported revenue by $8.7 million. Gross margin improved in product and service activities; management cited mix, operational efficiencies, and improved supply availability, while noting inflationary pressure.
- Segments: Device Solutions revenue was $118.3 million, down 15%; Networked Solutions was $313.5 million, up 12%; Outcomes was $62.9 million, up 10%. Segment operating income increased in all three segments, while corporate unallocated costs rose substantially.
- Geography: United States and Canada revenue was $372.8 million, versus $317.9 million; Europe, Middle East, and Africa was $98.7 million, versus $129.3 million; Asia Pacific was $23.0 million, versus $28.1 million.
- Cash flow: Operating cash flow fell mainly because of working-capital increases, partly offset by lower variable-compensation payouts. Capital expenditures were $6.9 million.
Balance sheet, debt, and liquidity
- At March 31, 2023, cash and cash equivalents were $196.0 million, compared with $202.0 million at year-end 2022. Total assets were $2.446 billion and total equity was $1.194 billion.
- Debt consisted of $460.0 million principal amount of 0% convertible notes due March 2026; carrying value, net of issuance costs, was $453.1 million. There were no revolver borrowings. Of the $500 million revolving facility, $437.9 million remained available after letters of credit.
- Management said existing cash, operating cash flow, and access to capital markets are expected to fund operations and commitments for at least the next 12 months and into the foreseeable future. The filing also identifies factors that could affect liquidity, including working capital, supply constraints, and market conditions.
- Working capital increased in the quarter: accounts receivable rose to $305.3 million from $280.4 million, inventory to $265.1 million from $228.7 million, and unearned revenue to $131.2 million from $95.6 million.
Material changes, outlook, and risks
- Restructuring: A new plan approved in February is expected to cost $44.2 million pretax, with $38.0 million recognized in Q1 and approximately 95% of total costs expected to be cash expenditures. Completion is targeted for early 2025; estimated annualized savings are $14–17 million after completion. Timing and savings may be affected by union/works-council consultation and regulatory approvals. Accrued restructuring liabilities were $75.7 million at quarter-end.
- Backlog and demand: Total backlog was $4.6 billion and 12-month backlog $1.9 billion, compared with $3.9 billion and $1.6 billion, respectively, a year earlier. Q1 bookings were $428 million. Remaining performance obligations were approximately $1.7 billion for the next 12 months and $1.8 billion thereafter. The company cautions that backlog and remaining obligations are not complete measures of future revenue and may be affected by cancellations, rescheduling, foreign exchange, and supply constraints.
- Management commentary: Itron reported no significant decrease in long-term customer demand, but some projects have delayed deliveries and revenue has shifted to future periods. Semiconductor and other supply constraints continue to affect shipment timing; recovery timing is uncertain. Raw-material, component, freight, and labor inflation may not be fully recovered through pricing.
- Other risks and unusual items: The company has limited direct exposure to Russia, Belarus, and Ukraine but warns of potential broader economic and supply-chain disruption. The Q1 GAAP loss was materially affected by restructuring expense; prior-year results included a restructuring credit and proceeds from the sale of certain gas product lines. The effective tax rate was 1%, affected by valuation allowances, geographic earnings mix, and other tax items. No specific full-year revenue or EPS guidance is provided in the filing text.
- The company reported compliance with credit-facility covenants and effective disclosure controls. It said it did not expect tax examinations to have a material adverse effect, while noting that the range of possible changes in unrecognized tax benefits could not be estimated.
Key facts for investors to verify
- Whether supply constraints ease and delayed customer deliveries convert into recognized revenue.
- Whether the $14–17 million annualized restructuring savings are achieved, and how much cash the plans require over time.
- Whether improved margins and non-GAAP earnings persist after adjusting for restructuring and other excluded items; compare these measures with GAAP results.
- How working-capital growth, particularly inventory and receivables, affects cash generation and free cash flow.
- Backlog quality, customer deployment schedules, termination rights, and the timing of the $4.6 billion total backlog.
- Liquidity and refinancing considerations, including the $460 million convertible-note maturity in 2026 and the revolving facility’s October 2024 maturity.